The specific matters of equity will be disclosed at the end

According to Huaren wholesale Cosmetic PP Bottles announcement, the acquisition of Korea will help Huaren Pharmaceutical to extend its existing medicine, medical services, preventive health care and other medical and health industries to skin care, beauty and other beauty and health industries. , To create two consumption upgrade scenarios for medicine and health + beauty and health, and create new profit growth points.

The third quarter report of Huaren Pharmaceutical in 2018 showed that its net profit attributable to shareholders of listed companies in the third quarter was approximately 11.44 million yuan, a year-on-year decrease of 22.11%. The net profit attributable to shareholders of listed companies in the first three quarters was approximately 27,853,400 yuan, a year-on-year increase 20.27%. There is a lot of speculation about the transaction between Hanhou and Huaren Pharmaceutical. In 2016, Hanhou had planned to go public, and in October of that year, Hanhou's first application for counselling registration was accepted. Since the transaction is still under negotiation, Wang Guoan referred to the transaction being negotiated with Huaren Pharmaceutical as capital operation. In this interview, he did not directly answer which party was more active in the transaction process. '

The specific matters of equity will be disclosed at the end, but in the business operation, at least in the cosmetics arena, we are the main one. I am a'veteran' in this field. In the future, the cosmetics industry will not be done by someone who understands capital. , But those who understand cosmetics can do it well with capital.' Wang Guoan said. Regarding why he participated in capital operation at this time, Wang Guoan said that he has recognized the importance of capital in the second half of the cosmetics industry, but it is mainly considered from the perspective of industrial development.

'If our cosmetics track is combined with the medicine track (there is more room for imagination), whether it is Pien Tze Huang, Buchang Pharmaceutical or Yunnan Baiyao, they are all going in the direction of medical beauty. We think this is Very important track.' Wang Guoan also said that in the past, the outside world's understanding of the Queen of Korea was focused on marketing, and capital can reshape and optimize the company's culture and brand. If the reorganization is successfully completed, Wang Guoan believes that the Korean queen will develop a 'dual main business' and try to enter the cosmeceuticals market. 'Chinese cosmeceuticals is still a false proposition, but the cracks in the door are already cracking.'